I understand that even the US results were not as statistically significant compared to Australia then why would the director of a reputed dermatology center would make such a statement. It appears to be some error in reporting or presentation of US trial results as the outcome appears to be positive.
Given that BOT has made a statement based on the results
This would indicate that if the investigators thought the phase 2 did not meet the primary or secondary endpoint, this will be the end of the acne trials. Given that BOT decided to take it to phase 3 would indicate that they are positive on the outcome irrespective of US data.
The market will react to the negative sentiment as the results are not clear or presented clearly, however, staying calm and not making rash uninformed decision could save you some $$$.
I am hoping to see a clarification about the US data before the opening bell. Good Luck to all holders.
JG
- Forums
- ASX - By Stock
- BOT
- BOT 1503 Study Analysis
BOT 1503 Study Analysis, page-16
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.0¢ |
Change
-0.020(5.26%) |
Mkt cap ! $660.6M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 35.0¢ | $2.298M | 6.325M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 543638 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 138254 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 543638 | 0.360 |
10 | 943850 | 0.355 |
13 | 837620 | 0.350 |
6 | 326675 | 0.345 |
12 | 1745026 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 138254 | 12 |
0.370 | 142311 | 9 |
0.375 | 529145 | 4 |
0.380 | 516215 | 16 |
0.385 | 205153 | 7 |
Last trade - 12.25pm 15/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |